BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26683245)

  • 1. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive aspergillosis in the recipients of liver retransplantation.
    Singh N; Pruett TL; Houston S; Muñoz P; Cacciarelli TV; Wagener MM; Husain S
    Liver Transpl; 2006 Aug; 12(8):1205-9. PubMed ID: 16598780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
    Fortún J; Martín-Davila P; Moreno S; Barcena R; de Vicente E; Honrubia A; García M; Nuño J; Candela A; Uriarte M; Pintado V
    J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.
    Balogh J; Gordon Burroughs S; Boktour M; Patel S; Saharia A; Ochoa RA; McFadden R; Victor DW; Ankoma-Sey V; Galati J; Monsour HP; Fainstein V; Li XC; Grimes KA; Gaber AO; Aloia T; Ghobrial RM
    Liver Transpl; 2016 Feb; 22(2):163-70. PubMed ID: 26515643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
    Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM;
    Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
    Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
    Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
    Lum L; Lee A; Vu M; Strasser S; Davis R
    Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
    Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
    Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
    Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for invasive aspergillosis in living donor liver transplant recipients.
    Osawa M; Ito Y; Hirai T; Isozumi R; Takakura S; Fujimoto Y; Iinuma Y; Ichiyama S; Tanaka K; Mishima M
    Liver Transpl; 2007 Apr; 13(4):566-70. PubMed ID: 17394155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive fungal infections in liver transplantation.
    Liu X; Ling Z; Li L; Ruan B
    Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk profile for invasive aspergillosis in liver transplant recipients.
    Rosenhagen M; Feldhues R; Schmidt J; Hoppe-Tichy T; Geiss HK
    Infection; 2009 Aug; 37(4):313-9. PubMed ID: 19629387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature.
    Ergin F; Arslan H; Azap A; Demirhan B; Karakayali H; Haberal M
    Transpl Int; 2003 Apr; 16(4):280-6. PubMed ID: 12730810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of aspergillosis in orthotopic liver transplant recipients].
    Liu ZW; Zou WL; Zhu XD; Zhang XL; Liu Y; Shen ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):171-4. PubMed ID: 15760547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.